emzeltrectinib   Click here for help

GtoPdb Ligand ID: 12377

Synonyms: example 36 [WO2018077246A1]
Compound class: Synthetic organic
Comment: This is the chemical structure for the INN emzeltrectinib. The structure is claimed in patent WO2018077246A1, as a neurotrophic receptor tyrosine kinase (NTRK) inhibitor [1]. Data from the patent indicates that the compound is equipotent against the 3 NTRK isoforms, TrkA, TrkB and TrkC.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 102.54
Molecular weight 376.13
XLogP 3.12
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES F[C@@H]1CN([C@H](C1)c1cc(F)ccc1F)c1ccn2c(n1)c(C(=O)N)c(n2)N
Isomeric SMILES C1[C@@H](CN([C@H]1c1c(ccc(c1)F)F)c1nc2c(c(nn2cc1)N)C(=O)N)F
InChI InChI=1S/C17H15F3N6O/c18-8-1-2-11(20)10(5-8)12-6-9(19)7-25(12)13-3-4-26-17(23-13)14(16(22)27)15(21)24-26/h1-5,9,12H,6-7H2,(H2,21,24)(H2,22,27)/t9-,12+/m0/s1
InChI Key YFTARXQOKASKBW-JOYOIKCWSA-N
References
1. Li Z, Hu Y, Wei W, Liguang D, Xiaowei D, Yanqing Y, Yinghui S, Yongxin H, Yong P, Fansheng K. (2018)
Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor.
Patent number: WO2018077246A1. Assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Beijing Sailintai Pharmaceutical Technology Co., Ltd., Lianyungang Runzhong Pharmaceutical Co., Ltd.. Priority date: 27/10/2017. Publication date: 03/05/2018.